Comparing different techniques that may help epilepsy patients take their medicines
Phase 3
- Conditions
- EpilepsyC10.228.140.490
- Registration Number
- RBR-943kwq
- Lead Sponsor
- Escola de Enfermagem da Universidade de São Paulo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruitment completed
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Patients, from both genders, aged between 18 and 100 years-old, diagnosed with epilepsy in ambulatory care for over one year, with at least four years of school, independent in daily life activities, without mental and psychic disabilities, presenting medium, or low adherence by the Morisky test.
Exclusion Criteria
Patients with medical prescription with weekly or daily increase or removal of anti-epileptic drugs, including Carbamazepine, phenytoin, phenobarbital and valproate sodium; those that already use the resources tested in this trial to enhance compliance and with other chronic diseases in continuous drug treatment.
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Achieve after one month of the application of the interventions increase or maintenance in therapeutic values anti-epileptic drugs blood levels; reduction of the number of epileptic crises, reported by the patient; enhance compliance by the evaluation of the Morisky test.
- Secondary Outcome Measures
Name Time Method Stability of the positive effects after six months of application of the interventions (increase or maintenance in therapeutic values anti-epileptic drugs blood levels; reduction of the number of epileptic crises, reported by the patient; enhance compliance by the evaluation of the Morisky test).